2024 HCPCS Code J7682
Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
TAGS: final milligrams inhalation through administered
| Short Description | Tobramycin non-comp unit |
| Product Note | 0135 |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Code Added Date | January 01, 2000 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J0650 - Inj, levothyroxine nos 10mcg
- J0651 - Inj, levothyroxine, freskabi
- J0652 - Inj, levothyroxine, hikma
- J0665 - Inj, bupivacaine, nos, 0.5mg
- J0670 - Inj mepivacaine hcl/10 ml
- J0687 - Inj cefazolin (wg crit care)
- J0688 - Inj cefazolin sodium, hikma
- J0689 - Inj cefazolin sodium, baxter
- J0690 - Cefazolin sodium injection
- J0691 - Inj lefamulin 1 mg
- J0692 - Cefepime hcl for injection
- J0693 - Inj., cefiderocol, 5 mg
- J0694 - Cefoxitin sodium injection
- J0695 - Inj ceftolozane tazobactam
- J0696 - Ceftriaxone sodium injection
- J0697 - Sterile cefuroxime injection
- J0698 - Cefotaxime sodium injection
- J0699 - Inj, cefiderocol, 10 mg
- J0701 - Inj. cefepime hcl (baxter)
- J0702 - Betamethasone acet&sod phosp
